Skip to content

CPIX

Cumberland Pharmaceuticals Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$6.79
+0.59%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+16.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Mar 20, 2026Krogulski Kenneth · directorA-Award4,000$2.80
Mar 20, 2026KAZIMI A J · director, 10 percent owner, officer: Chairman and CEOA-Award100,000$2.80
Mar 20, 2026Anthony Todd M. · officer: Vice Pres Organizational DevA-Award3,000$2.80
Mar 20, 2026Young Caroline · directorA-Award1,800$2.80
Mar 20, 2026Krogulski Kenneth · directorA-Award1,800$2.80
Mar 20, 2026Jones James · directorA-Award1,800$2.80
Mar 20, 2026Herman James L · officer: VP and Chief Compliance OfficeA-Award2,500$2.80
Mar 20, 2026Brown Martin S JR · directorA-Award1,800$2.80
Mar 20, 2026Bitterman Chris T. · officer: Vice Pres Sales & MarketingA-Award3,000$2.80
Mar 20, 2026Hamm John M. · officer: VP Chief Financial OfficerA-Award3,000$2.80
Mar 20, 2026Galante Joseph C · directorA-Award1,800$2.80
Sep 12, 2025Jones James · directorPurchase13$3.45
Sep 12, 2025Young Caroline · directorPurchase1$3.15
Sep 12, 2025Jones James · directorPurchase2$3.15
Sep 12, 2025Krogulski Kenneth · directorPurchase12$3.15
Sep 12, 2025KAZIMI A J · director, 10 percent owner, officer: Chairman and CEOPurchase13$3.45
Sep 12, 2025KAZIMI A J · director, 10 percent owner, officer: Chairman and CEOPurchase2$3.15
Sep 12, 2025Krogulski Kenneth · directorPurchase68$3.45
Sep 12, 2025Young Caroline · directorPurchase6$3.45
Aug 11, 2025KAZIMI A J · director, 10 percent owner, officer: Chairman and CEOPurchase13$3.50
Aug 11, 2025Krogulski Kenneth · directorPurchase80$3.37
Aug 11, 2025Jones James · directorPurchase13$3.50
Aug 11, 2025Young Caroline · directorPurchase8$3.37
Aug 11, 2025Young Caroline · directorPurchase6$3.50
Aug 11, 2025KAZIMI A J · director, 10 percent owner, officer: Chairman and CEOPurchase16$3.37
Aug 11, 2025Krogulski Kenneth · directorPurchase68$3.50
Aug 11, 2025Jones James · directorPurchase16$3.37
Jul 11, 2025Krogulski Kenneth · directorPurchase45$2.60
Jul 11, 2025Jones James · directorPurchase8$2.60
Jul 11, 2025Krogulski Kenneth · directorPurchase80$2.74
Institutional positioning

13F filings over the trailing two quarters

New 8Increased 8Reduced 10Sold out 29
FilerActionSharesFiled
IKARIAN CAPITAL, LLCReduced553,153May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced470,696May 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position361,759May 15, 2026
DIMENSIONAL FUND ADVISORS LPIncreased276,359May 7, 2026
PERCEPTIVE ADVISORS LLCReduced196,978May 29, 2026
BRIDGEWAY CAPITAL MANAGEMENT, LLCUnchanged163,468May 15, 2026
BOOTHBAY FUND MANAGEMENT, LLCReduced127,694May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased114,293May 15, 2026
CITADEL ADVISORS LLCIncreased96,491Sep 2, 2026
J. GOLDMAN & CO LPReduced81,040May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased73,500May 15, 2026
JANE STREET GROUP, LLCIncreased58,907May 12, 2026
BANK OF NEW YORK MELLON CORPReduced58,458May 5, 2026
BLACKROCK, INC.Increased56,891May 13, 2026
CITADEL ADVISORS LLCReduced49,743May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 20, 2026